王广树

作者: 时间:2021-07-02 点击数:

姓名

王广树

Guang-Shu Wang

职称

教授,博士生导师 Professor, Doctoral Supervisor

办公地点

伟德betvlctor1946 401 Room 401, School of Pharmaceutical Sciences

办公电话

0431-85619706

邮箱

wgs@jlu.edu.cn

教育背景

1980-1984 学士,中药专业,黑龙江中医学院中药系

1984-1987 硕士,药物化学,白求恩医科大学基础医学院

2002-2006 博士, 生物化学与分子生物学,BETVLCTOR伟德官方网站

1980-1984 Bachlor, Chinese Materia Medica, Department of Chinese materia medica, Heilongjiang College of Traditional Chinese Medicines

1984-1987 Master, Medicinal Chemistry, School of Basic Medicine, Norman Bethune Medical University

2002-2006 Ph.D., Biochemistry and Molecular Biology, School of Pharmaceutical Sciencese, Jilin University

工作经历

2013- 教授 博士生导师,BETVLCTOR伟德官方网站

2000-2013 教授 硕士生导师,BETVLCTOR伟德官方网站

1997-2000 教授,白求恩医科大学基础医学院

1995-1997 副教授,白求恩医科大学基础医学院

1992-1995 讲师,白求恩医科大学基础医学院

1987-1992 助教,白求恩医科大学基础医学院

2013- Prefessor & doctoral superviser, School of Pharmaceutical Sciencese, Jilin University

2000-2013 Prefessor & master superviser, School of Pharmaceutical Sciencese, Jilin University

1997-2000 Prefessor, School of Basic Medicine, Norman Bethune Medical University

1995-1997 Vice Prefessor, School of Basic Medicine, Norman Bethune Medical University

1992-1995 Lecturer, School of Basic Medicine, Norman Bethune Medical University

1987-1992 Assistant, School of Basic Medicine, Norman Bethune Medical University

主讲课程

生药学;高等有机化学

Pharmacognosy; Advanced Organic Chemistry

研究领域

中草药有效成分的研究

Active Chemical Constituents of Chinese Herbal Medicine

科研成果

科研项目

作为课题负责人获得过自然科学基金项目、科技部项目,主要有:

1. 国家重点研发计划中医药现代化研究,2018YFC1706105,珍稀濒危中药资源新来源的四种开发模式研究,2018/012-2021/12,135万元,子课题主持;

2. 国家“重大新药创制”科技重大专项,2013ZX09103002-007,治疗病毒性肝炎创新药物-YCZT的研究,20013/01-2016/12,112万元,已结题,主持;

3. 国家“重大新药创制”科技重大专项,2009ZX09502-011,中药药效物质基础及物质资源库研究关键技术,2009/01-2010/12,40万元,已结题,子课题主持;

4. 国家支撑计划,2006BAI06A18-17,中药五类新药刺人参苷的研究,2006/10-2009/10,40万元,已结题,主持;

5. 国家重点科技项目(攻关)计划,k94-14-01-03,抗恶性肿瘤新药人参甙-Rh2的研制,1996/01-1997/12,20万元,已结题,主持;

6. 国家自然科学基金面上项目,29302006,东北刺人参三萜皂甙有效成分研究,1994/01-1996/12,5万元,已结题。

Scientific research project hosted:

1.The national key research and development plans to modern research of traditional Chinese medicine, 2018 YFC1706105, four kinds of development pattern research on new sources of rare and endangered traditional Chinese medicine resources.

2.State "major drug discovery" science and technology major projects, 2013 ZX09103002-007, innovative drugs in the treatment of viral hepatitis-YCZT research.

3.The state "major drug discovery" science and technology major projects, 2009 ZX09502-011, traditional Chinese medicine medicinal material base, research on the key technologies of material resource.

4.The state support plan, 2006BAI06A18-17, Research of the fifth class of new Chinese medicine drugs, Cirenshen glycosides.

5.The national key project of science and technology (sci) plan, k94-14-01-03, research of new anti-malignant tumor drug , ginsenoside Rh2.

6.The national natural science foundation of China, 29302006, Studies on active triterpenoid saponins of Oplopanax elatus

近五年的代表性学术论文:

Representative academic papers of nearly five years:

1. Triterpenoid saponins from the herb Hylomecon japonica, Phytochemistry, 2020, 181, 112542.

2. Design, Synthesis and Biological Evaluation of 1-Phenyl-2-(phenylamino) Ethanone Derivatives as Novel MCR-1 Inhibitors, Molecules 2019, 24, 2719.

3. Simultaneous determination of six bioactive components of total flavonoids of Scorzonera austriaca in rat tissues by LC-MS/MS: application to a tissue distribution study, Revista Brasileira de Farmacognosia 28 (2018) 156-164.

4. New Triterpenoid Saponins from the Herb Hylomecon japonica, Molecules 2017, 22, 1731.

5. Development of an LC–MS/MS method for quantification of two pairs of isomeric flavonoid glycosides and other ones in rat plasma: Application to pharmacokinetic studies, Biomedical Chromatography. 2017;e3972.

6. Preparative Separation and Purification of the Total Flavonoids in Scorzonera austriaca with Macroporous Resins, Molecules, 2016, 21(6): 768.

7. Flavonoid Glycosides and Their Derivatives from the Herbs of Scorzonera austriacaWild, Molecules, 2016, 21(6): 803.

8. Pheonolic Compounds from the Fruits of Viburnum sargentii Koehne, Molecules, 2015, 20(8): 14377-14385.

版权所有 betvictor伟德 - bv伟德国际体育官方网站-始于英国1946